Literature DB >> 28834943

Clinical Characteristics of Benign Recurrent Vestibulopathy: Clearly Distinctive From Vestibular Migraine and Menière's Disease?

Babette F van Esch1, Erik van Wensen, Hester J van der Zaag-Loonen, Peter Paul G van Benthem, Roeland B van Leeuwen.   

Abstract

OBJECTIVE: We aimed to systematically investigate the clinical characteristics of benign recurrent vestibulopathy (BRV), vestibular migraine (VM), and Menière's disease (MD) and to assess whether clinical symptoms exist that are unique to BRV. STUDY
DESIGN: Prospective cohort study.
SETTING: Tertiary referral center.
METHODS: Between January 2015 and November 2016, patients were prospectively recruited at a specialized dizziness clinic. Patients were included if they met the diagnostic criteria for BRV, VM, or MD which was evaluated by simultaneous consultation of an otorhinolaryngologist and neurologist. All patients received a comprehensive clinical examination that included vestibular tests and pure-tone audiometry. A questionnaire was designed to systematically document symptoms of the three vestibular disorders.
RESULTS: A total of 122 patients were included in our study, 65 (53%) were females in whom 29 (24%) were postmenopausal. The mean age was 55.5 ± 13.7 years and the mean age of onset of vertigo attacks was 49.2 ± 14.8 years (n = 119). Forty-five (37%) patients had a clinical diagnosis of BRV, 34 (28%) of VM, and 43 (35%) of MD. No symptom could be identified which was specifically linked to BRV. In patients with BRV, similar to those with VM, we found a female preponderance (p = 0.05 in BRV, p = 0.001 in VM). Patients with VM reported significantly more often a positive history of motion sickness (p = 0.01). In addition, canal paresis was most profound in patients with MD (p = 0.001).
CONCLUSION: We found no clinical characteristics that were distinctive for BRV. However, we did find several distinctive clinical features for VM and MD which may assist the physician in their history taking.

Entities:  

Mesh:

Year:  2017        PMID: 28834943     DOI: 10.1097/MAO.0000000000001553

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

1.  Vestibular and audiometric results after endolymphatic mastoid shunt surgery in patients with Menière's disease.

Authors:  Jennifer L Spiegel; Ivelina Stoycheva; Bernhard G Weiss; Mattis Bertlich; Tobias Rader; Martin Canis; Friedrich Ihler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-15       Impact factor: 3.236

2.  Positive Relationship Between Paroxysmal Vertigo and Right-to-Left Shunt: A Large Observational Study.

Authors:  Kaiming Liu; Xiulin Tian; Wenwu Hong; Yujin Xiao; Juanyan Chen; Haidi Jin; Faming Wang; Xiaopei Xu; Tao Zang; Liang Zhang; Mengxiong Pan; Xiaodong Zou
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

3.  Benign Recurrent Vertigo: The Course of Vertigo Attacks Compared to Patients With Menière's Disease and Vestibular Migraine.

Authors:  Roeland B van Leeuwen; Carla Colijn; Babette F van Esch; Tjard R Schermer
Journal:  Front Neurol       Date:  2022-03-02       Impact factor: 4.003

4.  Recurrent Vestibular Symptoms Not Otherwise Specified: Clinical Characteristics Compared With Vestibular Migraine and Menière's Disease.

Authors:  Julia Dlugaiczyk; Thomas Lempert; Jose Antonio Lopez-Escamez; Roberto Teggi; Michael von Brevern; Alexandre Bisdorff
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

Review 5.  The "hype" of hydrops in classifying vestibular disorders: a narrative review.

Authors:  Marly F J A van der Lubbe; Akshayaa Vaidyanathan; Vincent Van Rompaey; Alida A Postma; Tjasse D Bruintjes; Dorien M Kimenai; Philippe Lambin; Marc van Hoof; Raymond van de Berg
Journal:  J Neurol       Date:  2020-11-17       Impact factor: 4.849

6.  Development and validation of the dizziness symptoms questionnaire in Thai-outpatients.

Authors:  Ravin Suvanich; Uraiwan Chatchawan; Chanchai Jariengprasert; Kwanchanok Yimtae; Torkamol Hunsawong; Alongkot Emasithi
Journal:  Braz J Otorhinolaryngol       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.